Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Accounts payable

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndAccounts payable (Million USD)YoY (%)
Dec 31, 20236+4.82%
Dec 31, 20226+74.86%
Dec 31, 20213+24.82%
Dec 31, 20203-50.28%
Dec 31, 20195-10.43%
Dec 31, 20186+16.52%
Dec 31, 20175-44.01%
Dec 31, 20169+53.10%
Dec 31, 20156-28.68%
Dec 31, 20148-2.37%
Dec 31, 20139+11.71%
Dec 31, 20128-1.81%
Dec 31, 20118

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)